Cited 203 time in
Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Dae Wook | - |
| dc.contributor.author | Seo, Kyung Hye | - |
| dc.contributor.author | Curtis-Long, Marcus J. | - |
| dc.contributor.author | Oh, Kyeong Yeol | - |
| dc.contributor.author | Oh, Jong-Won | - |
| dc.contributor.author | Cho, Jung Keun | - |
| dc.contributor.author | Lee, Kon Ho | - |
| dc.contributor.author | Park, Ki Hun | - |
| dc.date.accessioned | 2022-12-26T23:18:49Z | - |
| dc.date.available | 2022-12-26T23:18:49Z | - |
| dc.date.issued | 2014-02 | - |
| dc.identifier.issn | 1475-6366 | - |
| dc.identifier.issn | 1475-6374 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/19171 | - |
| dc.description.abstract | Severe acute respiratory syndrome coronavirus (SARS-CoV) papain-like protease (PLpro) is a key enzyme that plays an important role in SARS virus replication. The ethanol extract of the seeds of Psoralea corylifolia showed high activity against the SARS-CoV PLpro with an IC50 of value of 15 mu g/ml. Due to its potency, subsequent bioactivity-guided fractionation of the ethanol extract led to six aromatic compounds (1-6), which were identified as bavachinin (1), neobavaisoflavone (2), isobavachalcone (3), 4'-O-methylbavachalcone (4), psoralidin (5) and corylifol A (6). All isolated flavonoids (1-6) inhibited PLpro in a dose-dependent manner with IC50 ranging between 4.2 and 38.4 mu M. Lineweaver-Burk and Dixon plots and their secondary replots indicated that inhibitors (1-6) were mixed inhibitors of PLpro. The analysis of K-I and K-IS values proved that the two most promising compounds (3 and 5) had reversible mixed type I mechanisms. | - |
| dc.format.extent | 5 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | INFORMA HEALTHCARE | - |
| dc.title | Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.3109/14756366.2012.753591 | - |
| dc.identifier.scopusid | 2-s2.0-84893506372 | - |
| dc.identifier.wosid | 000330850300011 | - |
| dc.identifier.bibliographicCitation | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, v.29, no.1, pp 59 - 63 | - |
| dc.citation.title | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | - |
| dc.citation.volume | 29 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 59 | - |
| dc.citation.endPage | 63 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
| dc.subject.keywordPlus | RESPIRATORY SYNDROME CORONAVIRUS | - |
| dc.subject.keywordPlus | DEUBIQUITINATING ENZYME | - |
| dc.subject.keywordPlus | TYROSINASE | - |
| dc.subject.keywordAuthor | Mixed type I inhibition | - |
| dc.subject.keywordAuthor | papain-like protease inhibitor | - |
| dc.subject.keywordAuthor | Psoralea corylifolia | - |
| dc.subject.keywordAuthor | severe acute respiratory syndrome coronavirus papain-like protease | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
